Form D · Biotechnology
Accutar Biotechnology Inc.
Brooklyn, NY · CIK 0001783798
Offering snapshot reported Jan 5, 2021 · SEC filing
- Reported sold
- $28.5M Offering amount: $28.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 4, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 5, 2021 | Initial | $28,452,239 | No comparison | 5 | SEC filing |
| Sep 2, 2020 | Initial | $20,000,000 | No comparison | 1 | SEC filing |
| Aug 1, 2019 | Initial | $27,999,952 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-385251
Source: Form D, filed Jan 5, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jie Fan | Director, Executive |
| Wei He | Executive |
| Ke Liu | Executive |
| Yimin Qian | Executive |
| Xiangyan Sun | Executive |
| Quan Zhou | Director |
| Long Zhu | Director |
| Ling Zou | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
760 Parkside Avenue, Suite 213
Brooklyn, NY, 11226
Brooklyn, NY, 11226